首页> 外文期刊>Open Journal of Nephrology >Tuberculosis of Exceptional Location in a Haemodialysis Patient
【24h】

Tuberculosis of Exceptional Location in a Haemodialysis Patient

机译:血液透析患者异常部位的结核病

获取原文
           

摘要

Background: Chronic haemodialysis patients present a lack of immunity responsible for a high incidence of tuberculosis of atypical and non-pulmonary localizations. Observation: We present a clinical case of a haemodialysis patient that presents an isolated localisation of prostate tuberculosis. He had no clinical signs but had laboratory findings of inflammatory syndrome and high Prostatic Antigen (PSA) level. The diagnosis was made by histopathologic study of the piece of prostatectomy. The patient received a six-month treatment with an initial two-month phase involving four anti-tuberculosis drugs (Rifampicin, Isoniazid, Ethambutol and Pyrazinamid) followed by a four-month maintenance phase involving two drugs (Isoniazid and Rifampicin). All drugs were adapted to his dialysis condition. We noticed no side effects of drugs. Conclusion: Clinical signs of prostatic tuberculosis are not specific, mainly made of an obstructive symptom. The diagnosis of prostatic tuberculosis is based on a bundle of clinical and biological arguments. Koch Bacilli (KB) can rarely be found in urine or sperm. In haemodialysis patient, it can be masked by non specific aspect of inflammatory syndrome. The management must be adjusted and a close following up of side effects is necessary.
机译:背景:慢性血液透析患者缺乏免疫力,导致非典型和非肺部结核高发。 观察:我们介绍了一名血液透析患者的临床病例,该患者表现出孤立的前列腺结核病定位。他没有临床体征,但有炎症综合征和高前列腺抗原(PSA)水平的实验室检查结果。该诊断是通过对前列腺切除术的组织病理学研究做出的。该患者接受为期六个月的治疗,最初的两个月阶段涉及四种抗结核药物(利福平,异烟肼,乙胺丁醇和吡嗪酰胺),随后为期四个月的维持阶段,涉及两种药物(异烟肼和利福平)。所有药物都适应他的透析条件。我们没有发现药物有任何副作用。 结论:前列腺结核的临床体征不是特异性的,主要是由阻塞性症状引起的。前列腺结核的诊断基于一系列临床和生物学论证。尿液或精液中很少发现Koch Bacilli(KB)。在血液透析患者中​​,它可以被炎性综合征的非特异性方面所掩盖。必须调整管理,并密切跟踪副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号